mevalonic acid and Epithelial Ovarian Cancer

mevalonic acid has been researched along with Epithelial Ovarian Cancer in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Glogova, A; Haagsma, J; Pereira, M; Petrik, J; Shepherd, TG; Stewart, J1
DiMattia, G; Greenaway, JB; Hardy, D; Osz, K; Petrik, J; Revay, T; Shepherd, T; Virtanen, C1

Other Studies

2 other study(ies) available for mevalonic acid and Epithelial Ovarian Cancer

ArticleYear
Mutant p53 murine oviductal epithelial cells induce progression of high-grade serous carcinoma and are most sensitive to simvastatin therapy in vitro and in vivo.
    Journal of ovarian research, 2023, Nov-20, Volume: 16, Issue:1

    Topics: Animals; Carcinoma, Ovarian Epithelial; Epithelial Cells; Fallopian Tubes; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Mevalonic Acid; Mice; Ovarian Neoplasms; Simvastatin; Tumor Suppressor Protein p53

2023
Ovarian tumour growth is characterized by mevalonate pathway gene signature in an orthotopic, syngeneic model of epithelial ovarian cancer.
    Oncotarget, 2016, Jul-26, Volume: 7, Issue:30

    Topics: Animals; Apoptosis; Carcinoma, Ovarian Epithelial; Cell Line, Tumor; Cell Movement; Cell Proliferation; Female; Genomic Instability; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Mevalonic Acid; Mice; Mice, Inbred C57BL; Neoplasms, Glandular and Epithelial; Ovarian Neoplasms; Polyisoprenyl Phosphates; Simvastatin; Tumor Microenvironment

2016